Sign In
Buy BNTX
$90.58
-2.27 (-2.44%)
At Close: Jul 31, 2026
Dow, Nasdaq Up Triple Digits as Oil Prices Cool Off
11:40am, Tuesday, 10'th Mar 2026
The Dow and Nasdaq are sporting triple-digit leads this afternoon as oil prices take a breather
Inflation & fixed income: Regan Capital’s strategy
11:00am, Tuesday, 10'th Mar 2026
Regan Capital chief investment officer Skyler Weinand talked with Proactive's Stephen Gunnion about how rising interest rates, inflation, and global...
BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture
08:40am, Tuesday, 10'th Mar 2026
With both companies focusing on their respective strategic priorities, BioNTech expects to maximize value for patients and shareholders alike.
BioNTech co-founders set to launch new mRNA venture as company sharpens oncology focus
07:53am, Tuesday, 10'th Mar 2026
BioNTech SE (NASDAQ:BNTX) co-founders Ugur Sahin and Özlem Türeci plan to launch a new independent biotech company focused on next-generation mRNA...
Scientists behind COVID-19 vaccine will depart BioNTech
07:40am, Tuesday, 10'th Mar 2026
The company's co-founders said they are leaving to start a new mRNA-based company.
Breakfast News: Top Rule Breakers Look To Innovate
07:30am, Tuesday, 10'th Mar 2026
Vertex pops on fast-track chances, Oracle leads notable Tuesday earnings, and more
BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock.
07:18am, Tuesday, 10'th Mar 2026
The German biotech provides a weak full-year outlook and announces the exit of its co-founders.
374Water secures Orlando approval to launch waste destruction services at Iron Bridge
07:00am, Tuesday, 10'th Mar 2026
374Water Inc (NASDAQ:SCWO, FRA:8LL) announced that it has received approval from the City of Orlando to provide waste destruction services at the Iron...
BioNTech Cofounders to Leave to Form New Company
06:50am, Tuesday, 10'th Mar 2026
The company said its cofounders were leaving to form a biotechnology startup focused on developing messenger RNA.
BioNTech's founding couple Sahin, Tuereci to leave to set up new venture
06:49am, Tuesday, 10'th Mar 2026
The cofounders of BioNTech , Ugur Sahin and Oezlem Tuereci, will leave the COVID-19 vaccine maker by the end of 2026 to set up their own new company, the biotech firm said on �
BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate Update
06:45am, Tuesday, 10'th Mar 2026
BioNTech on track for a catalyst-rich year with six late-stage data readouts expected across immunomodulators, antibody-drug conjugates and mRNA cancer immunotherapies Increased focus on PD-L11/VEGF-A
Mainz, Germany, March 10, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) today announced plans for an independent company to be established and led by BioNTe
Wall Street Week Ahead
07:23am, Sunday, 08'th Mar 2026
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
Cathie Wood Loads Up on Alibaba and Amazon -- Sells TSMC and Baidu
07:05am, Wednesday, 04'th Mar 2026
Cathie Wood's ARK Invest exchange-traded funds adjusted several holdings on March 3, adding to select technology and aviation names while trimming others.Among
BioNTech (BNTX) Expected to Announce Quarterly Earnings on Monday
02:30am, Monday, 02'nd Mar 2026
BioNTech (NASDAQ: BNTX - Get Free Report) will likely be posting its Q4 2025 results before the market opens on Monday, March 9th. Analysts expect the company to announce earnings of ($0.57) per share
